septerna novo - Search News

Order byBest matchMost fresh

Novo Nordisk Inks $2.2B Deal With Septerna

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.

· 12h · on MSN

· 1d · on MSN

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal

Contract Pharma · 3h

Novo Nordisk Invests $2.2B in Septerna’s Oral Drugs

Novo Nordisk and Septerna Collaborate on Oral Medicines for Obesity and Other Diseases

Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including over $200 million in upfront and near-term milestone payments.

· 12h

Ignore The Noise - Novo Nordisk Is A Clear Buy

STAT · 1d

Novo Nordisk strikes deal with Septerna to develop obesity pills

Yahoo Finance8h

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market. The collaboration aims to develop oral small-molecule treatments targeting G ...